Search results for brain tumor.
Found 8 clinical studies.
C4471001 A Two-Part, Phase 1A/B, Open-Label, Multicenter Trial Evaluating Pharmacokinetics, Safety And Efficacy Of Pf 07284890 (Arry 461) In Participants With Braf V600 Mutant Solid Tumors With And Without Brain Involvement
- Investigator: Trisha Wise-Draper
- Posted Date: Dec 15, 2021
- Type of Study: Drug
A071702 A Phase II Study Of Checkpoint Blockade Immunotherapy In Patients With Somatically Hypermutated Recurrent Glioblastoma
- Investigator: Soma Sengupta
- Posted Date: May 24, 2021
- Type of Study: Drug
Uccc-Bn-19-01- Detecting Tumor-Derived Cell-Free Dna In Csf Of Glioblastoma Patients And Determining The Correlation To Tumor Burden And Prognosis
- Investigator: Jonathan Forbes
- Posted Date: Sep 11, 2020
- Type of Study: Observational/Survey
A Randomized, Placebo Controlled Phase 2B/3 Study Of Abt-414 With Concurrent Chemoradiation And Adjuvant Temozolomide In Subjects With Newly Diagnosed
- Investigator: Rekha Chaudhary
- Posted Date: May 15, 2019
- Type of Study: Drug
Phase II Double-Blinded Placebo-Controlled Study Of Bevacizumab With Or Without Amg 386 In Patients With Recurrent Glioblastoma Or Gliosarcoma.
- Investigator: Kevin Redmond
- Posted Date: May 15, 2019
- Type of Study: Drug
A Phase 2 Evaluation Of Trc105 In Combination With Bevacizumab For The Treatment Of Recurrent Or Progresisve Gliblastoma That Has Progressed On Bevaci
- Investigator: Rekha Chaudhary
- Posted Date: May 15, 2019
- Type of Study: Drug
A Novel Biomarker Study In Subjects With Newly Diagnosed Primary Glioblastoma Multiforme (Gbm)
- Investigator: Rekha Chaudhary
- Posted Date: May 15, 2019
- Type of Study: Observational/Survey
Phase II Trial Of Smo/ Akt/ Nf2/Cdk Inhibitors In Progressive Meningiomas With Smo/ Akt/ Nf2/Cdk Pathway Mutations
- Investigator: Rekha Chaudhary
- Posted Date: May 15, 2019
- Type of Study: Drug